My contribution to ASCO 2014: 1. A phase 3 randomized double-blind trial of maintenance with niraparib versus placebo in patients with platinum-sensitive ovarian cancer (ENGOT-OV16/NOVA trial). | 2014 ASCO Annual Meeting Abstracts ... Lorusso, Jorn Herrstedt, Shefali Agarwal, Robert E. Martell, Mansoor Raza Mirza; Dana-Farber Cancer Institute, Boston, MA; University Medical Center Hamburg-Eppendorf, ... Terms matched: 1 - URL: abstracts.asco.org/144/AbstView_144_134260.html 2. Preclinical and early clinical activity of the oral selective inhibitor of nuclear export (SINE) exportin 1 (XPO1) antagonist KPT-330 (Selinexor) in patients (pts) with platinum-resistant/refractory ovarian cancer (OvCa). | 2014 ASCO Annual Meeting Abstracts ... , Jean-Richard Saint-Martin, Eran Shacham, Darcy Vincett, Michael Kauffman, Mansoor Raza Mirza, Morten Sorensen; Mount Sinai School of Medicine, New York, NY ... Terms matched: 1 - URL: abstracts.asco.org/144/AbstView_144_134382.html 3. A phase 1 dose-escalation study of the oral selective inhibitor of nuclear export (SINE) KPT-330 (selinexor) in patients (pts) with heavily pretreated non-Hodgkin lymphoma (NHL). | 2014 ASCO Annual Meeting Abstracts ... Jacobsen, Vishal Kukreti, Roger E. Tiedemann, Tami Rashal, Mansoor Raza Mirza, Sharon Shacham, Michael Kauffman, John Kuruvilla; John Theurer Cancer Center ... Terms matched: 1 - URL: abstracts.asco.org/144/AbstView_144_134559.html 4. A phase 1b food effect study of the first-in-class, oral, selective inhibitor of nuclear export (SINE) selinexor (KPT-330) in patients (pts) with advanced sarcomas. | 2014 ASCO Annual Meeting Abstracts ... , Tracey Marshall, Yosef Landesman, Michael Kauffman, Sasha Rebello, Mansoor Raza Mirza, Gary K. Schwartz, Albiruni R. A. Razak; Memorial ... Terms matched: 1 - URL: abstracts.asco.org/144/AbstView_144_133618.html 5. The MEK Inhibitor in Low-Grade Serous Ovarian Cancer (MILO)/ENGOT-ov11 study: A multinational, randomized, open-label phase 3 study of binimetinib (MEK162) versus physicians choice chemotherapy in patients with recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum. | 2014 ASCO Annual Meeting Abstracts ... Hilpert, Robert L. Coleman, Eric Pujade-Lauraine, Sandro Pignata, Mansoor Raza Mirza, Amit M. Oza, Josep M. del Campo, Martin Klaus ... Terms matched: 1 - URL: abstracts.asco.org/144/AbstView_144_132611.html 6. Independent review of AGO-OVAR 12, a GCIG/ENGOT-Intergroup phase III trial of nintedanib (N) in first-line therapy for ovarian cancer (OC). | 2014 ASCO Annual Meeting Abstracts ... Rainer Kimmig, Susanne Malander, Florence Joly, Nikolaus De Gregorio, Mansoor Raza Mirza, Jacobus Pfisterer, Tomas Minarik, Sandro Pignata, Michael Merger, Andreas ... Terms matched: 1 - URL: abstracts.asco.org/144/AbstView_144_130341.html 7. A first-in-class, first-in-human phase I trial of KPT-330 (selinexor), a selective inhibitor of nuclear export (SINE) in patients (pts) with advanced solid tumors. | 2014 ASCO Annual Meeting Abstracts ... Lillian L. Siu, Philippe L. Bedard, Hemchandra Mahaseth, Mansoor Raza Mirza, Amit Mahipal; Department of Oncology, Rigshospitalet, Copenhagen, Denmark; ... Terms matched: 1 - URL: abstracts.asco.org/144/AbstView_144_130941.html 8. Genomic alterations in paired pretreatment (pre) and progression (prog) tumor samples from ovarian cancer patients (pts) treated with pazopanib (pazo) or placebo (plb). | 2014 ASCO Annual Meeting Abstracts ... , Alexander Burges, Kosei Hasegawa, Annette Jahn, Nuria Laínez, Mansoor Raza Mirza, Tjoung-Won Park-Simon, Sandrina Lambrechts, Yuan Liu, Anthony DAmelio, Catherine ... Terms matched: 1 - URL: abstracts.asco.org/144/AbstView_144_131722.html 9. A phase III trial of postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate- or high-risk endometrial cancer. ENGOT-EN2-DGCG/EORTC 55102. | 2014 ASCO Annual Meeting Abstracts ... experience with a suggested or customized itinerary! Author(s ): Mansoor Raza Mirza, Caroline Lundgren, Frederic Kridelka, Annamaria Ferrero, Frederic Amant; Danish ... Terms matched: 1 - URL: abstracts.asco.org/144/AbstView_144_126940.html
Posted on: Sat, 24 May 2014 10:50:31 +0000